Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-08-15 06:01 am Purchase | 13G | Timber Pharmaceuticals Inc. TMBR | INTRACOASTAL CAPITAL LLC | 5,763,596 4.200% | 5,763,596 (New Position) | View |
| 2022-02-14 09:40 am Sale | 13G | Timber Pharmaceuticals Inc. TMBR | Altium Capital Management LP | 5,878,414 4.990% | -3,000,000 (-33.79%) | View |
| 2022-02-04 3:39 pm Purchase | 13G | Timber Pharmaceuticals Inc. TMBR | Hudson Bay Capital Management LP | 2,574,834 3.880% | 1,239,387 (+92.81%) | View |
| 2022-01-18 11:19 am Purchase | 13G | Timber Pharmaceuticals Inc. TMBR | Empery Asset Management LP | 9,866,540 4.990% | 781,250 (+8.60%) | View |
| 2021-09-09 07:33 am Sale | 13D | Timber Pharmaceuticals Inc. TMBR | TardiMed Sciences LLC | 3,308,567 9.000% | -425,000 (-11.38%) | View |
| 2021-09-01 5:28 pm Sale | 13D | Timber Pharmaceuticals Inc. TMBR | TardiMed Sciences LLC | 3,733,567 10.200% | -400,500 (-9.69%) | View |
| 2021-08-26 6:47 pm Sale | 13D | Timber Pharmaceuticals Inc. TMBR | TardiMed Sciences LLC | 4,134,067 11.300% | -649,915 (-13.59%) | View |
| 2021-06-10 6:11 pm Sale | 13D | Timber Pharmaceuticals Inc. TMBR | TardiMed Sciences LLC | 4,783,982 13.000% | -653,535 (-12.02%) | View |
| 2021-02-16 4:13 pm Purchase | 13G | Timber Pharmaceuticals Inc. TMBR | Altium Capital Management LP | 8,878,414 9.990% | 7,513,036 (+550.25%) | View |
| 2021-02-10 6:50 pm Purchase | 13G | Timber Pharmaceuticals Inc. TMBR | Hudson Bay Capital Management LP | 1,335,447 9.990% | 1,335,447 (New Position) | View |
| 2021-01-28 2:30 pm Purchase | 13G | Timber Pharmaceuticals Inc. TMBR | Empery Asset Management LP | 9,085,290 9.990% | 7,719,912 (+565.40%) | View |
| 2020-09-24 4:08 pm Sale | 13D | Timber Pharmaceuticals Inc. TMBR | TardiMed Sciences LLC | 5,437,517 45.200% | -228,635 (-4.04%) | View |
| 2020-05-28 8:59 pm Purchase | 13G | Timber Pharmaceuticals Inc. TMBR | Altium Capital Management LP | 1,365,378 9.900% | 1,365,378 (New Position) | View |
| 2020-05-28 5:00 pm Purchase | 13D | Timber Pharmaceuticals Inc. TMBR | TardiMed Sciences LLC | 5,666,152 47.700% | 5,666,152 (New Position) | View |
| 2020-05-27 5:23 pm Purchase | 13G | Timber Pharmaceuticals Inc. TMBR | Empery Asset Management LP | 1,365,378 9.990% | 1,365,378 (New Position) | View |
| 2020-02-13 4:30 pm Purchase | 13G | Timber Pharmaceuticals Inc. TMBR | Vivo Capital VIII LLC | 539,926 3.400% | 539,926 (New Position) | View |
| 2020-01-30 4:29 pm Purchase | 13D | Timber Pharmaceuticals Inc. TMBR | Timber Pharmaceuticals LLC | 2,255,336 12.900% | 2,255,336 (New Position) | View |
| 2020-01-15 10:05 am Purchase | 13G | Timber Pharmaceuticals Inc. TMBR | Empery Asset Management LP | 2,464,158 4.990% | 2,464,158 (New Position) | View |